التفاصيل البيبلوغرافية
العنوان: |
Treatment preference and quality of life impact: Ravulizumab vs eculizumab for atypical hemolytic uremic syndrome |
المؤلفون: |
Mauch, Teri J, Chladek, Michael R, Cataland, Spero, Chaturvedi, Shruti, Dixon, Bradley P, Garlo, Katherine, Gasteyger, Christoph, Java, Anuja, Leguizamo, Jorge, Lloyd-Price, Lucy, Pham, Tan P, Symonds, Tara, Tomazos, Ioannis, Wang, Yan |
المصدر: |
2020-Current year OA Pubs |
بيانات النشر: |
Digital Commons@Becker |
سنة النشر: |
2023 |
المجموعة: |
Washington University School of Medicine: Digital Commons@Becker |
مصطلحات موضوعية: |
Adult, Humans, Child, Middle Aged, Atypical Hemolytic Uremic Syndrome, Quality of Life, Antibodies, Monoclonal, Humanized, Complement Inactivating Agents, ICTS (Institute of Clinical and Translational Sciences), Medicine and Health Sciences |
نوع الوثيقة: |
text |
وصف الملف: |
application/pdf |
اللغة: |
unknown |
العلاقة: |
https://digitalcommons.wustl.edu/oa_4/2212Test; https://digitalcommons.wustl.edu/context/oa_4/article/3209/viewcontent/Treatment_preference_and_quality.pdfTest |
DOI: |
10.57264/cer-2023-0036 |
الإتاحة: |
https://doi.org/10.57264/cer-2023-0036Test https://digitalcommons.wustl.edu/oa_4/2212Test https://digitalcommons.wustl.edu/context/oa_4/article/3209/viewcontent/Treatment_preference_and_quality.pdfTest |
رقم الانضمام: |
edsbas.28E23C1C |
قاعدة البيانات: |
BASE |